Mark McMillan

Dr Mark McMillan

Grant-Funded Researcher (A)

Adelaide Medical School

Faculty of Health and Medical Sciences

Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.


Mark McMillan moved from a clinical background as a Registered Nurse, working across a broad range of disciplines, including Aboriginal primary health care, infection control, renal dialysis, rehabilitation, public health, high dependency, and tropical infectious diseases. In 2008, he began his research career at the Menzies School of Health Research in Darwin. In 2013, he joined the Vaccine Trials Research Unit at the Women's and Children's Hospital, Adelaide.

Dr. McMillan completed his PhD in May 2021, receiving a Dean’s Commendation and The Alice Davey Award for his work on meningococcal carriage and disease, which contributed to national immunisation strategies for meningococcal B disease.

Since 2020, Dr. McMillan has led the Vaccine Program Evaluation team at the Women's and Children's Hospital, conducting commissioned reviews for SA Health, including evaluations of South Australia's COVID-19 vaccine program and school immunisation program. He has also led three commissioned evaluations and drafting of advice for the Australian Technical Advisory Group on Immunisation (ATAGI).

Dr. McMillan is a Chief Investigator (CIJ) on the Centre for Research Excellence in Neisseria Disease Control (NEIS CRE), which focuses on developing public health strategies to reduce the burden of invasive meningococcal disease (IMD) and gonorrhoea. In 2023, he was awarded the Women’s & Children’s Hospital Foundation Postdoctoral Fellowship to investigate the long-term effects of COVID-19 and influenza infection on the health and wellbeing of children and adolescents.

2024    CIJ - Centre for Research Excellence in Neisseria disease control (CIA Marshall, $3 million).

2023    CIA - Women’s & Children’s Hospital Foundation Postdoctoral Fellowship – ‘long-COVID and repeat infections on the health and wellbeing of children and adolescents’ ($386,384).

2022    CIA - RRI Engaging Opportunities program – ‘Generating evidence to inform the introduction of maternal group B streptococcal vaccination to reduce stillbirth and infant death’ ($10,000).

2020    Co-investigator on a study investigating the long-term effectiveness of meningococcal B vaccine (4CMenB) against gonorrhoea (CIAs Marshall and Ward, $1 million).

  • Position: Grant-Funded Researcher (A)
  • Phone: 81618105
  • Email: mark.mcmillan@adelaide.edu.au
  • Campus: Womens & Childrens Hospital
  • Building: WCH - Clarence Rieger Building, floor 2
  • Org Unit: Women's and Children's Health

Connect With Me
External Profiles